O
Oma Fertility
A full-service fertility clinic that brings top lab design and technology to in-house treatments like IUI and IVF
About Oma Fertility
Oma Fertility operates as a network of fertility clinics that integrates artificial intelligence and robotics with a human-centric approach to care. Founded in 2020 by Gurjeet Singh, PhD, Sahil Gupta, MD, and Kiran Joshi, PhD, the company aims to improve the success rates and affordability of fertility treatments. The inspiration for the company came after CEO Gurjeet Singh learned of a couple who faced bankruptcy after multiple unsuccessful and costly IVF cycles. This experience, combined with his background as CEO of AI software platform Ayasdi and his connection with his co-founders, sparked the venture. Sahil Gupta brought his experience as the founder of Aveya, a chain of fertility clinics in India and Nepal, while Kiran Joshi contributed his expertise in electrical engineering from his PhD at Stanford alongside Singh.
The company's business model is built on vertical integration, establishing its own clinics to directly implement its proprietary technology, thereby controlling the patient experience and cost structure. Revenue is generated directly from patients for a range of fertility services, including IVF, IUI, and egg freezing. Oma Fertility positions itself with an "ethical pricing" model, offering treatments at a fraction of the national average cost to make care more accessible. For instance, an IVF cycle is priced significantly lower than the typical market rate. The company targets a broad range of clients, including both heterosexual and LGBTQIA+ couples and individuals facing fertility challenges. The company has secured $37.5 million in total funding, comprising $29 million in equity from investors like JAZZ Venture Partners and Root Ventures, and an $8.5 million debt facility.
A core component of Oma Fertility's service is its FDA-registered patented technology, Oma Sperm InSight™. This AI-powered tool assists embryologists in identifying the most promising sperm cell for in-vitro fertilization. By analyzing a much larger number of sperm cells than is possible with traditional manual methods, the technology aims to enhance the probability of creating a viable embryo. This focus on improving sperm selection is a key differentiator, as it addresses a critical, often overlooked, variable in the IVF process. The company's treatment packages also include intracytoplasmic sperm injection (ICSI) as a standard feature, rather than an expensive add-on. By increasing the chances of success in fewer cycles, the company aims to reduce the significant financial and emotional burden on patients. The first clinic opened in Santa Barbara in 2021, and the network has since expanded to cities including Atlanta, New York, and St. Louis.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 18
- Open positions
- None listed
- Dealroom signal
- 42.0/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Fertility, Biotechnology, Femtech, Biotech and Pharma, Reproductive Health, Hard Tech, DT and LS
- Business model
- Marketplace & ecommerce
- Client focus
- B2C
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Jun 2022 | $29M | $116M | JAZZ Venture Partners · Freesolo Ventures · Mithril · Global Asset Capital | ↗ |
| DEBT✓Debt | Jun 2022 | $8.5M | — | Standard Treasury · Silicon Valley Bank | ↗ |
Growth signals
Latest recorded traffic for Oma Fertility is 480 monthly website visits, up 0% over the last three months. Oma Fertility's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Oma Fertility in the Santa Barbara ecosystem
The Oma Fertility office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
- JPJAZZ Venture Partners
Freesolo Ventures
Mithril
Global Asset Capital
Root
Series B and later2 investors entered at this stage
Standard Treasury
Silicon Valley Bank
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Oma Fertility on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Oma Fertility’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









